CREBBP and diffuse large B-cell lymphoma: Moreover, CREBBP/EP300-mutant DLBCL patients were found to have higher serum levels of the immunosuppressive cytokine IL-10 compared to the pro-inflammatory cytokine IL-1β (Huang et al., 2021), suggesting potential systemic immune suppression in these patients.